The impacts of neoadjuvant chemotherapy and of debulking surgery on survival from advanced ovarian cancer (Q87399723)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25026637%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

title

The impacts of neoadjuvant chemotherapy and of debulking surgery on survival from advanced ovarian cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25026637%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference

3

Sarah Ferguson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25026637%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

9

Steven A Narod

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25026637%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

author name string

Barry Rosen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25026637%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Stephane Laframboise

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25026637%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Jason Dodge

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25026637%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Marcus Bernardini

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25026637%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Joan Murphy

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25026637%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Yakir Segev

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25026637%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Ping Sun

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25026637%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

publication date

12 July 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25026637%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25026637%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

volume

134

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25026637%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25026637%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

page(s)

462-467

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25026637%20AND%20SRC:MED&resulttype=core&format=json

Aggressive surgical effort and improved survival in advanced-stage ovarian cancer

9 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.07.004

Procedures required to accomplish complete cytoreduction of ovarian cancer: is there a correlation with "biological aggressiveness" and survival?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.07.004

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.07.004

Intraperitoneal cisplatin and paclitaxel in ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.07.004

Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.07.004

Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.07.004

Primary surgery or neoadjuvant chemotherapy in ovarian cancer: what is the value of comparing apples with oranges?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.07.004

Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.07.004

An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC-NCIC trial of PDS vs neoadjuvant chemotherapy (NACT)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.07.004

7 January 2021

Adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.07.004

Long-term ovarian cancer survival associated with mutation in BRCA1 or BRCA2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.07.004

10.1016/J.YGYNO.2014.07.004

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25026637%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference